Related references
Note: Only part of the references are listed.Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome
Marian C. Okondo et al.
CELL CHEMICAL BIOLOGY (2018)
Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias
K. Wang et al.
LEUKEMIA (2017)
DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis
Marian C. Okondo et al.
NATURE CHEMICAL BIOLOGY (2017)
Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages
Cornelius Y. Taabazuing et al.
CELL CHEMICAL BIOLOGY (2017)
BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis
Frederik Otzen Bagger et al.
NUCLEIC ACIDS RESEARCH (2016)
Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins
L. Wagner et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Acute myeloid leukaemia
Asim Khwaja et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity
Daniel A. Bachovchin et al.
NATURE CHEMICAL BIOLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function
Baptiste Guey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation
Nina Van Opdenbosch et al.
NATURE COMMUNICATIONS (2014)
Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9
Hui Zhang et al.
MOLECULAR CANCER RESEARCH (2013)
Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity
P. A. Spagnuolo et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors
Meghaan P. Walsh et al.
PLOS ONE (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Proteolytic Processing of Nlrp1b Is Required for Inflammasome Activity
Bradley C. Frew et al.
PLOS PATHOGENS (2012)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis
Noa Novershtern et al.
CELL (2011)
CARD8 and NLRP1 Undergo Autoproteolytic Processing through a ZU5-Like Domain
Andrea D'Osualdo et al.
PLOS ONE (2011)
Differential Requirement for Caspase-1 Autoproteolysis in Pathogen-Induced Cell Death and Cytokine Processing
Petr Broz et al.
CELL HOST & MICROBE (2010)
Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor
Jia-Jing Wu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
Robert M. Eager et al.
BMC CANCER (2009)
Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
R. M. Eager et al.
CLINICAL ONCOLOGY (2009)
Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9.: Part 2:: Isoindoline containing inhibitors
Sebastiaan Van Goethem et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The NLR gene family: A standard nomenclature
Jenny P. -Y. Ting et al.
IMMUNITY (2008)
Talabostat
Charles Casey Cunningham
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes - Potential importance of selectivity over dipeptidyl peptidases 8 and 9
GR Lankas et al.
DIABETES (2005)
Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8
WT Jiaang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
L Agostini et al.
IMMUNITY (2004)
PT-100, a small molecule dipeptidyl peptidase inhibitorg has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism
S Adams et al.
CANCER RESEARCH (2004)
Proyl peptidases: a serine protease subfamily with high potential for drug discovery
JS Rosenblum et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis
M Razmara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
